-based genetic counseling referrals for breast cancer patients. An oncology-focused adaptation of the QI Knowledge Application Tool (QI-KAT), a validated QI assessment, was administered pre- and post-intervention. Three educators scored each de-identified exam
Search Results
Rachel Hae-Soo Joung, Brianna Marie D'Orazio, Jeana Springmann, Julie Johnson, Karl Y. Bilimoria, and Anthony D. Yang
Robin M. Lally, Elizabeth Reed, and Roksana Zak
Background: Adherence to National Comprehensive Cancer Network (NCCN) guidelines improves breast cancer therapy outcomes. While physician guideline adherence is often high, room for improvement exists. Shared surgical decision making, genetic
Mina Shenouda, Vivek Yadala, Jennifer Dotson, and Toni Pacioles
is expected to cause about 45,750 deaths during 2019. The current NCCN Guidelines recommend genetic counseling and germline testing in all PC pts. This recommendation was based on evidence that germline genetic mutations were identified in 5.5% of all
Filipa Lynce and Claudine Isaacs
results; the ability of the current model of genetic counseling practices to deal with the increase in patient volume; and the cost-effectiveness of such an approach. 8 , 9 One way of minimizing the identification of VUS, the impact of false
Margaret Tempero
reducing lifestyle risks that they can actually control? Considering the expanding need, the workforce shortage in genetic counseling is increasing to epic proportions, and I don't think there is a solution in sight. So I guess this is another call to
Julia R. Trosman, Christine B. Weldon, Michael P. Douglas, Allison W. Kurian, R. Kate Kelley, Patricia A. Deverka, and Kathryn A. Phillips
despite informed consent and genetic counseling, patients may not understand the immature state of evidence about numerous genes within panels (73%) and that their data are used for research, to which many would object if better informed. Payers' suspicion
Maxim Ivanov, Margarita Sharova, Andrea Olsen, Alexandra Lebedeva, Ekaterina Ignatova, Gerald Mouse, and Vladislav Mileyko
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 1 provide substantial groundwork for specialist practice in diverse fields: medical oncology, genetic
Sean Dineen, Patrick M. Lynch, Miguel A. Rodriguez-Bigas, Sarah Bannon, Melissa Taggart, Colleen Reeves, Cathy Modaro, Michael Overman, George J. Chang, John M. Skibber, and Y. Nancy You
chemotherapy regimens. 20 However, in practice, adherence to this guideline is poor, 21 , 22 and many patients are not referred for genetic counseling and workup. 23 We hypothesized that system-based practice intervention, designed with the Six Sigma quality
Lynn A. McCain, Kara J. Milliron, Amanda M. Cook, Robert Paquette, Jasmine B. Parvaz, Susan D. Ernst, Anne L. Kittendorf, Diane M. Harper, Philip Zazove, Jim Arthurs, Jerry A. Tippie, Bailey Hulswit, Lee F. Schroeder, David F. Keren, and Sofia D. Merajver
genetic counseling. In an integrated health system, 6 <30% of patients had family history documented in the medical record. As a result, there is a pressing need to improve genetics clinics’ efficiency, given the increasing number of patients being
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
Featured Updates to the NCCN Guidelines
Mary B. Daly, Robert Pilarski, Matthew B. Yurgelun, Michael P. Berry, Saundra S. Buys, Patricia Dickson, Susan M. Domchek, Ahmed Elkhanany, Susan Friedman, Judy E. Garber, Michael Goggins, Mollie L. Hutton, Seema Khan, Catherine Klein, Wendy Kohlmann, Allison W. Kurian, Christine Laronga, Jennifer K. Litton, Julie S. Mak, Carolyn S. Menendez, Sofia D. Merajver, Barbara S. Norquist, Kenneth Offit, Tuya Pal, Holly J. Pederson, Gwen Reiser, Kristen Mahoney Shannon, Kala Visvanathan, Jeffrey N. Weitzel, Myra J. Wick, Kari B. Wisinski, Mary A. Dwyer, and Susan D. Darlow
Jewish ancestry, 1 , 2 , 4 , 5 providing some evidence to support population-based genetic testing among the Ashkenazi Jewish population. However, the panel raised concerns about the demand on genetic counseling resources, the preparedness of healthcare
